JUNS Stock Summary and Trading Ideas (Jupiter Neurosciences | NASDAQ:JUNS)

Jupiter Neurosciences Inc is a clinical stage research and development pharmaceutical company located in Jupiter, Florida. The company has developed a unique resveratrol platform product primarily targeting treatment of neuro-inflammation. Its platform product, JOTROL, offers potential therapeutic benefit to most central nervous system diseases such as Alzheimer's disease, ataxias, and metabolic disorders such as Lysosomal Storage Disorders and mitochondrial diseases.

Jupiter Neurosciences trades on the NASDAQ stock market under the symbol JUNS.

As of April 4, 2025, JUNS stock price declined to $0.59 with 90,944 million shares trading.

JUNS has a beta of -3.22, meaning it tends to be less sensitive to market movements. JUNS has a correlation of 0.06 to the broad based SPY ETF.

JUNS has a market cap of $19.43 million. This is considered a Sub-Micro Cap stock.

The top ETF exchange traded funds that JUNS belongs to (by Net Assets): IWC.

JUNS support price is $.58 and resistance is $.67 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that JUNS shares will trade within this expected range on the day.